Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1
Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1
复制标题
DOI:
10.1016/j.bbrc.2015.05.097
复制
发表时间:
2015-08-14
影响因子:
3.1
通讯作者:
Bae, Sun Sik
中科院分区:
文献类型:
--
作者:
Ha, Jung Min;Yun, Sung Ji;Bae, Sun Sik
Mammalian target of rapamycin complex (mTORC) regulates various cellular processes including proliferation, growth, migration and differentiation. In this study, we showed that mTORC1 regulates platelet-derived growth factor (PDGF)-induced phenotypic conversion of vascular smooth muscle cells (VSMCs). Stimulation of contractile VSMCs with PDGF significantly reduced the expression of contractile marker proteins in a time- and dose-dependent manner. In addition, angiotensin II (AngII)-induced contraction of VSMCs was completely blocked by the stimulation of VSMCs with PDGF. PDGF-dependent suppression of VSMC marker gene expression was significantly blocked by inhibition of phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase (ERK), and mTOR whereas inhibition of p38 MAPK had no effect. In particular, inhibition of mTORC1 by rapamycin or by silencing of Raptor significantly blocked the PDGF-dependent phenotypic change of VSMCs whereas silencing of Rictor had no effect. In addition, loss of AngII-dependent contraction by PDGF was significantly retained by silencing of Raptor. Inhibition of mTORC1 by rapamycin or by silencing of Raptor significantly blocked PDGF-induced proliferation of VSMCs. Taken together, we suggest that mTORC1 plays an essential role in PDGF-dependent phenotypic changes of VSMCs. (C) 2015 Elsevier Inc. All rights reserved.